blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1863792

EP1863792 - ATP COMPETITIVE KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.11.2009
Database last updated on 16.09.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [2009/04]For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton NJ 05843-4000 / US
Former [2007/50]For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543-4000 / US
Inventor(s)01 / GAVAI, Ashvinikumar V.
12 Stonewall Drive
Princeton Junction, New Jersey 08550 / US
02 / CHEN, Ping
21 Derby Chase Court
Belle Mead, New Jersey 08502 / US
03 / ZHAO, Yufen
83 Chicory Lane
Pennington, New Jersey 08534 / US
 [2007/50]
Representative(s)Hart-Davis, Jason, et al
Cabinet Beau de Loménie
158, rue de l'Université
75340 Paris Cedex 07 / FR
[N/P]
Former [2007/50]Hart Davis, Jason, et al
Cabinet Beau de Loménie, 158, rue de l'Université
75340 Paris Cedex 07 / FR
Application number, filing date06739676.227.03.2006
[2007/50]
WO2006US11023
Priority number, dateUS20050665826P28.03.2005         Original published format: US 665826 P
[2007/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006104971
Date:05.10.2006
Language:EN
[2006/40]
Type: A1 Application with search report 
No.:EP1863792
Date:12.12.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 05.10.2006 takes the place of the publication of the European patent application.
[2007/50]
Type: B1 Patent specification 
No.:EP1863792
Date:21.01.2009
Language:EN
[2009/04]
Search report(s)International search report - published on:EP05.10.2006
ClassificationIPC:C07D401/06, C07D471/04, C07D401/14, A61K31/495, A61P35/00, A61P19/02
[2007/50]
CPC:
C07D471/04 (EP,US); A61P19/02 (EP); A61P35/00 (EP);
C07D401/06 (EP,US); C07D401/14 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/50]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:KOMPETITIVE ATP-KINASEHEMMER[2007/50]
English:ATP COMPETITIVE KINASE INHIBITORS[2007/50]
French:INHIBITEURS DE KINASE EXERCANT UNE ACTION ANTIPROLIFERATIVE[2007/50]
Entry into regional phase04.09.2007National basic fee paid 
04.09.2007Designation fee(s) paid 
04.09.2007Examination fee paid 
Examination procedure04.09.2007Amendment by applicant (claims and/or description)
04.09.2007Examination requested  [2007/50]
24.01.2008Despatch of a communication from the examining division (Time limit: M04)
26.05.2008Reply to a communication from the examining division
14.07.2008Communication of intention to grant the patent
07.11.2008Fee for grant paid
07.11.2008Fee for publishing/printing paid
Opposition(s)22.10.2009No opposition filed within time limit [2009/53]
Fees paidRenewal fee
14.03.2008Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT21.01.2009
BE21.01.2009
CY21.01.2009
CZ21.01.2009
DK21.01.2009
EE21.01.2009
FI21.01.2009
LT21.01.2009
LV21.01.2009
NL21.01.2009
PL21.01.2009
RO21.01.2009
SI21.01.2009
SK21.01.2009
TR21.01.2009
IE27.03.2009
LU27.03.2009
MC31.03.2009
BG21.04.2009
SE21.04.2009
GR22.04.2009
IS21.05.2009
PT22.06.2009
HU22.07.2009
[2011/44]
Former [2011/33]AT21.01.2009
BE21.01.2009
CZ21.01.2009
DK21.01.2009
EE21.01.2009
FI21.01.2009
LT21.01.2009
LV21.01.2009
NL21.01.2009
PL21.01.2009
RO21.01.2009
SI21.01.2009
SK21.01.2009
IE27.03.2009
LU27.03.2009
MC31.03.2009
BG21.04.2009
SE21.04.2009
GR22.04.2009
IS21.05.2009
PT22.06.2009
HU22.07.2009
Former [2011/22]AT21.01.2009
BE21.01.2009
CZ21.01.2009
DK21.01.2009
EE21.01.2009
FI21.01.2009
LT21.01.2009
LV21.01.2009
NL21.01.2009
PL21.01.2009
RO21.01.2009
SI21.01.2009
SK21.01.2009
IE27.03.2009
LU27.03.2009
MC31.03.2009
BG21.04.2009
SE21.04.2009
GR22.04.2009
IS21.05.2009
PT22.06.2009
Former [2011/04]AT21.01.2009
BE21.01.2009
CZ21.01.2009
DK21.01.2009
EE21.01.2009
FI21.01.2009
LT21.01.2009
LV21.01.2009
NL21.01.2009
PL21.01.2009
RO21.01.2009
SI21.01.2009
SK21.01.2009
IE27.03.2009
MC31.03.2009
BG21.04.2009
SE21.04.2009
GR22.04.2009
IS21.05.2009
PT22.06.2009
Former [2010/14]AT21.01.2009
BE21.01.2009
CZ21.01.2009
DK21.01.2009
EE21.01.2009
FI21.01.2009
LT21.01.2009
LV21.01.2009
NL21.01.2009
PL21.01.2009
RO21.01.2009
SI21.01.2009
SK21.01.2009
IE27.03.2009
MC31.03.2009
BG21.04.2009
SE21.04.2009
IS21.05.2009
PT22.06.2009
Former [2010/07]AT21.01.2009
BE21.01.2009
CZ21.01.2009
DK21.01.2009
EE21.01.2009
FI21.01.2009
LT21.01.2009
LV21.01.2009
NL21.01.2009
PL21.01.2009
RO21.01.2009
SI21.01.2009
SK21.01.2009
IE27.03.2009
MC31.03.2009
SE21.04.2009
IS21.05.2009
PT22.06.2009
Former [2010/03]AT21.01.2009
BE21.01.2009
CZ21.01.2009
DK21.01.2009
EE21.01.2009
FI21.01.2009
LT21.01.2009
LV21.01.2009
NL21.01.2009
PL21.01.2009
RO21.01.2009
SI21.01.2009
SK21.01.2009
MC31.03.2009
SE21.04.2009
IS21.05.2009
PT22.06.2009
Former [2009/29]NL21.01.2009
Cited inInternational search[A]EP0882717  (KYOWA HAKKO KOGYO KK [JP]) [A] 1-19 * pages 1-2; example 103 *;
 [A]WO0121597  (ASTRAZENECA AB [SE], et al) [A] 1-19 * pages 1-2; example 11 *;
 [A]WO03042172  (BRISTOL MYERS SQUIBB CO [US], et al) [A] 1-19 * pages 1-2; example 66 *;
 [A]WO2004113324  (ASTRAZENECA AB [SE], et al) [A] 1-19 * pages 1-2; tables 1,2 *;
 [E]WO2006069395  (BRISTOL MYERS SQUIBB CO [US], et al) [E] 1-19* pages 1-2; compound 78B *
by applicantUS10146P
 WO03042172
 US2003186983
 US2004044203
 WO2005066176
 US2005182058
 US2005197339
 WO2006069365
    - SCHLESSINGER J., "Cell signaling by receptor tyrosine kinases", CELL, (2000), vol. 103, no. 2, pages 211 - 225
    - COBLEIGH, M. A. ET AL., "Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease", J. OF CLIN. ONCOL., (1999), vol. 17, no. 9, pages 2639 - 2648
    - BASELGA, J. ET AL., "Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin", J. CLIN. ONCOL., (2000), vol. 18, no. 4, pages 904 - 914
    - SATOH, K. ET AL., "Involvement of ErbB-2 in rheumatoid synovial cell growth", ARTHRITIS RHEUM., (2001), vol. 44, no. 2, pages 260 - 265
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.